Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story
- Autori: Stoian A.P.; Catrinoiu D.; Rizzo M.; Ceriello A.
- Anno di pubblicazione: 2021
- Tipologia: Nota o commento
- OA Link: http://hdl.handle.net/10447/549445
Abstract
Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.